Jasen Gundersen never considered a career in business when he entered medical school nearly three decades ago to become a rural primary care doctor.
Innovative CAR-T cells effectively target glioblastoma with reduced toxicity
Glioblastoma is the most common and most aggressive primary brain tumor, with an average survival after diagnosis of less than two years, and against which
September 26, 2024